Beyond Traditional Risk Scores
For decades, cardiac surgery decisions have relied on risk calculators like the STS Predicted Risk of Mortality and EuroSCORE II. These models use 20–40 variables to estimate operative risk. They work — but they have known limitations: they were built on historical populations, they do not account for certain anatomic nuances, and they struggle with rare combinations of risk factors.
AI-powered clinical decision support addresses these gaps by analyzing orders of magnitude more data points, identifying non-linear relationships between variables, and learning from continuously updated outcomes data.
What AI Can Do Today
Current applications of AI in cardiac surgical planning include:
- Enhanced risk stratification — Machine learning models that incorporate imaging data, lab trends, and comorbidity interactions to refine operative risk beyond STS/EuroSCORE
- Treatment pathway optimization — Comparing projected outcomes for CABG vs. PCI, repair vs. replacement, or surgical vs. transcatheter approaches based on patient-specific anatomy
- Guideline concordance analysis — Automatically comparing a proposed surgical plan against ACC/AHA, ESC, and AATS guidelines to flag potential discordances
- Surgeon-volume matching — Identifying which surgeons at which institutions have the highest volume and best outcomes for a specific procedure type
- Natural language processing — Extracting structured clinical data from unstructured medical records, operative reports, and imaging studies
What AI Cannot Do
AI is a decision support tool, not a decision maker. It cannot:
- Replace the clinical judgment of an experienced surgeon or cardiologist
- Account for patient preferences, values, and life circumstances
- Perform the surgery itself (despite advances in robotic assistance)
- Guarantee outcomes — it provides probabilities, not certainties
The most effective model combines AI-generated analysis with expert physician review. The AI identifies patterns and flags considerations; the physician interprets them in the context of the whole patient.
The WhiteGloveMD Approach: Clintelligence™
At WhiteGloveMD, we built Clintelligence™ — a multi-agent AI platform purpose-built for cardiac surgical decision support. Rather than using a single monolithic model, Clintelligence™ employs specialized agents that each handle a specific aspect of the clinical analysis:
- One agent normalizes and ingests medical records
- Another extracts clinical signals and identifies the primary pathology
- A dedicated risk intelligence agent runs STS, EuroSCORE II, and proprietary composite scoring
- A clinical reasoning engine synthesizes all findings into actionable recommendations
- And the final output is always reviewed and co-signed by two board-certified physicians
This architecture ensures that AI augments — never replaces — the physician’s role. Every White Glove Insights™ report carries dual physician signatures: a cardiac surgeon and a cardiologist who have independently reviewed both the AI analysis and the raw clinical data.
What This Means for Patients
For patients facing cardiac surgery, AI-assisted second opinions mean:
- Faster turnaround — What once took weeks can be delivered in 48 hours
- More comprehensive analysis — No detail in your records is missed
- Guideline transparency — You see exactly how your case maps to published evidence
- Confidence — Knowing that both AI analysis and expert physicians agree on your plan
The future of cardiac surgery decisions is not AI or physicians. It is AI and physicians, working together, with the patient at the center.